AB CarVal Insurance Dedicated Fund Series of the SALI Multi-Series Fund, L.P. reported $53,184,563 sold under an exempt securities offering whose total size is listed as indefinite. Investors have a disclosed view of Capital raised to date, while the offering’s stated ceiling remains indefinite.
Key Highlights
- The offering’s reported commencement date was February 5, 2026.
- SALI Fund Partners, LLC is identified as the general partner and director.
- The filing is a Form D/A notice for an exempt securities offering.
AB CarVal Insurance Dedicated Fund Series of the SALI Multi-Series Fund, L.P. has sold $53,184,563 through an exempt securities offering with an indefinite total offering amount. The capital figure identifies securities sold to date, while the offering’s overall size remains listed as indefinite.
Offering Details and Fund Structure
The offering is marked under the 3(c)(7) exemption. Its reported date is February 5, 2026, and the securities offering amount is listed as indefinite. The fund series is based at 6850 Austin Center Boulevard, Suite 300, Austin, Texas 78,731, with the contact number 5,127,357,254. Cameron Vail signed the notice on September 1, 2026, on behalf of AB CarVal Insurance Dedicated Fund Series of the SALI Multi-Series Fund, L.P.
FAQs
Q: How much has AB CarVal Insurance Dedicated Fund Series sold?
A: AB CarVal Insurance Dedicated Fund Series has sold $53,184,563 through its exempt securities offering. The offering’s total size is listed as indefinite.
Q: What is the impact of the AB CarVal Insurance fund offering?
A: The filing reports $53,184,563 in securities sold under the offering. It also lists the total offering amount as indefinite, so no fixed overall offering amount is stated.
Q: Who manages the SALI Multi-Series Fund offering?
A: SALI Fund Partners, LLC is identified in the filing as the general partner and director. Cameron J. Vail is listed as managing director of the general partner.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.